Data
Sources
and Data Issues:
|
From Registry or EHR/EMR if available.
If Chart Audit, then sample from the
sample frame of persons meeting denominator
criteria.
Note: This measure has frequently been
selected, due to the ready accessibility
of data, when the grantee participates
in the Chronic Disease Collaborative for
diabetes. Enrolled patients frequently
represent a small subset of diabetics
seen at a CHC, and if there are multiple
sites, may represent performance at only
one site. This raises questions about
how representative is the data in PECS,
or whatever database is used to track
these patients. |
|
An estimated
7% of the U.S. population has diabetes.
Diabetes is widely recognized as one of
the leading causes of death and disability
in the U.S. In 2002, it was estimated
that diabetes cost the U.S. $132 billion
in such areas as disability payments,
time lost from work, premature death,
hospitalizations, medical care, etc.
Diabetes is associated with long-term
complications affecting almost every part
of the body. If uncontrolled, diabetes
can lead to blindness, heart and blood
vessel disease, stroke, kidney failure,
amputations, and nerve damage. In addition,
complications of pregnancy and birth defects
are common in babies of diabetic mothers.
For more information, see:
http://diabetes.niddk.nih.gov/dm/pubs/overview/index.htm
Minority populations are disproportionately
affected by diabetes. From 1980 through
2004, the age-adjusted prevalence of diagnosed
diabetes increased among all sex-race
groups examined. From 1980 through 2004,
the age-adjusted prevalence of diagnosed
diabetes was higher among blacks than
whites and highest among black females.
During this time period, age-adjusted
prevalence increased 76% among white males,
65% among white females, 68% among black
males and 37% among black females. Among
Hispanics, the age-adjusted prevalence
among males and females were higher in
2004 than in 1997.”CDC. National
diabetes fact sheet: general information
and national estimates on diabetes in
the United States, 2005. Atlanta, GA:
US Department of Health and Human Services,
CDC; 2005. See: http://www.cdc.gov/diabetes/pubs/factsheet05.htm
For additional information on this and
related measures, see:
http://www.healthdisparities.net/hdc/html/collaboratives.topics.diabetes.aspx
The measurement and monitoring of levels
of HgA1C is the barometer for diabetes
control.
“Lowering A1C has been associated
with a reduction of micro vascular and
neuropathic complications of diabetes…with
an A1C goal of <7%.”
Standards of medical care in diabetes.
Diabetes Care. 2004 Jan; 27 Suppl 1:S15-35.
See: http://care.diabetesjournals.org/cgi/reprint/27/suppl_1/s15
For the clinical practice guidelines
that go with this measure, see:
http://www.diabetes.org/for-health-professionals-and-scientists/cpr.jsp
|